Ligand Pharmaceuticals
LGND
LGND
210 hedge funds and large institutions have $1.17B invested in Ligand Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 72 increasing their positions, 71 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3.61% more ownership
Funds ownership: 90.1% → 93.71% (+3.6%)
1% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 71
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
210
Holding in Top 10
1
Calls
$4.48M
Puts
$2.88M
Top Buyers
| 1 | +$14.5M | |
| 2 | +$13.7M | |
| 3 | +$10.3M | |
| 4 |
BlackRock
New York
|
+$8.66M |
| 5 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$8.65M |
Top Sellers
| 1 | -$9.2M | |
| 2 | -$5.19M | |
| 3 | -$3.74M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$2.47M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$2.2M |